IL-15 DCs can be obtained by culturing monocytes from blood in IL-15 instead of IL-4 in standard protocols, and the resulting DCs have an increased capacity to stimulate NK cells cytotoxicity, which could be a crucial contribution in anti-tumor efficacy of DC vaccines [130]. Here, IL15 is linked to neoplasm.